ABG-WTT Global Life Science Capital Partners GP Ltd Activity Q4 2020-Q3 2023

Q3 2023
 Value Shares↓ Weighting
NewRAYZEBIO INC$17,292,068778,92282.98%
MDVL SellMEDAVAIL HOLDINGS INC$1,803,528
-51.0%
300,588
-98.0%
8.66%
-87.1%
Q2 2023
 Value Shares↓ Weighting
MDVL NewMEDAVAIL HOLDINGS INC$3,683,72615,029,48066.84%
NewRAPID MICRO BIOSYSTEMS INC$1,038,2961,038,29618.84%
LUNG NewPULMONX CORP$789,27460,20414.32%
Q4 2022
 Value Shares↓ Weighting
LUNG ExitPULMONX CORP$0-60,204-6.26%
ExitRAPID MICRO BIOSYSTEMS INC$0-1,038,296-20.94%
MDVL ExitMEDAVAIL HOLDINGS INC$0-15,029,480-72.80%
Q2 2022
 Value Shares↓ Weighting
MDVL NewMEDAVAIL HOLDINGS INC$22,995,00015,029,48081.12%
NewRAPID MICRO BIOSYSTEMS INC$4,465,0001,038,29615.75%
LUNG NewPULMONX CORP$886,00060,2043.13%
Q4 2021
 Value Shares↓ Weighting
LUNG ExitPULMONX CORP$0-93,831-22.93%
MDVL ExitMEDAVAIL HOLDINGS INC$0-3,885,951-77.07%
Q2 2021
 Value Shares↓ Weighting
MDVL NewMEDAVAIL HOLDINGS INC$47,603,0003,885,95192.00%
LUNG NewPULMONX CORP$4,140,00093,8318.00%

Compare quarters

Export ABG-WTT Global Life Science Capital Partners GP Ltd's holdings